Does LENVATINIB Cause Hyperkeratosis? 64 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 64 reports of Hyperkeratosis have been filed in association with LENVATINIB (Lenvima). This represents 0.2% of all adverse event reports for LENVATINIB.
64
Reports of Hyperkeratosis with LENVATINIB
0.2%
of all LENVATINIB reports
5
Deaths
33
Hospitalizations
How Dangerous Is Hyperkeratosis From LENVATINIB?
Of the 64 reports, 5 (7.8%) resulted in death, 33 (51.6%) required hospitalization, and 1 (1.6%) were considered life-threatening.
Is Hyperkeratosis Listed in the Official Label?
Yes, Hyperkeratosis is listed as a known adverse reaction in the official FDA drug label for LENVATINIB.
What Other Side Effects Does LENVATINIB Cause?
Diarrhoea (4,262)
Hypertension (4,152)
Fatigue (3,603)
Decreased appetite (3,257)
Malignant neoplasm progression (2,929)
Nausea (2,492)
Blood pressure increased (2,228)
Vomiting (1,962)
Asthenia (1,643)
Malaise (1,602)
What Other Drugs Cause Hyperkeratosis?
CABOZANTINIB S-MALATE (411)
ADALIMUMAB (332)
SUNITINIB MALATE (170)
ETANERCEPT (168)
SORAFENIB (150)
METHOTREXATE (149)
VEMURAFENIB (145)
REGORAFENIB (136)
RIPRETINIB (124)
RITUXIMAB (121)
Which LENVATINIB Alternatives Have Lower Hyperkeratosis Risk?
LENVATINIB vs LEPONEX
LENVATINIB vs LERCANIDIPINE
LENVATINIB vs LETAIRIS
LENVATINIB vs LETERMOVIR
LENVATINIB vs LETROZOLE